Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-28

FDA Approved: CYRED EQ — Supplemental Application (Afaxys Pharma, LLC)

View source ↗

Summary

The FDA approved a supplemental application for CYRED EQ, a desogestrel/ethinyl estradiol oral contraceptive, submitted by Afaxys Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYRED EQ (Desogestrel and Ethinyl Estradiol)

Snippet

SUPPL AP for CYRED EQ (DESOGESTREL AND ETHINYL ESTRADIOL)